Bromodomain Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 7757 | AZ 13824374 |
| Potent and selective ATAD2 bromodomain inhibitor | |
| 5970 | BAY 299 |
| Potent and selective BRD1 and TAF1 inhibitor | |
| 5266 | BAZ2-ICR |
| Selective BAZ2 inhibitor | |
| 5590 | BI 9564 |
| Potent and selective BRD9 and BRD7 inhibitor; orally active | |
| 4758 | Bromosporine |
| Broad spectrum bromodomain inhibitor | |
| 7139 | CeMMEC1 |
| TAF1 inhibitor | |
| 5331 | CPI 203 |
| BET bromodomain inhibitor; arrests cell cycle at G1 phase | |
| 7644 | FHT 1015 |
| Potent and selective SMARCA4/2 inhibitor | |
| 7645 | FHT 2344 New |
| Potent SMARCA2/4 inhibitor | |
| 5385 | GSK 5959 |
| Potent and selective BRPF1 inhibitor | |
| 6198 | GSK 6853 |
| Potent and selective BRPF1 inhibitor | |
| 4650 | I-BET 151 dihydrochloride |
| BET bromodomain inhibitor; also promotes differentiation of hiPSCs into megakaryocytes | |
| 6521 | I-BET 762 |
| Potent and high affinity BET bromodomain inhibitor; anti-inflammatory; orally bioavailable. | |
| 5591 | I-BRD9 |
| Potent and selective BRD9 inhibitor | |
| 7458 | iBET-BD2 |
| Potent and selective pan-BD2 inhibitor; orally bioavailable | |
| 4695 | Ischemin sodium salt |
| CBP inhibitor; cell permeable | |
| 4499 | (+)-JQ1 |
| Potent and selective BET bromodomain inhibitor; cell permeable | |
| 6251 | L Moses dihydrochloride |
| High affinity and selective PCAF bromodomain inhibitor | |
| 6068 | Lin28 1632 |
| Bromodomain inhibitor; also RNA binding protein Lin28 inhibitor and promotes mESC differentiation | |
| 5496 | LP 99 |
| Selective BRD7 and BRD9 inhibitor | |
| 5173 | MS 436 |
| Potent and selective BRD4(1) inhibitor | |
| 5546 | NI 57 |
| Potent and selective BRPF bromodomain inhibitor | |
| 7482 | NVS MLLT-1 |
| Selective MLLT1/3 inhibitor | |
| 5744 | NVS-CECR2-1 |
| Potent and selective CECR2 inhibitor | |
| 5289 | OF 1 |
| Selective BRPF1B and BRPF2 inhibitor | |
| 6181 | OTX 015 |
| BET bromodomain inhibitor; orally bioavailable | |
| 4928 | OXF BD 02 |
| Selective BRD4(1) inhibitor | |
| 4445 | PFI 1 |
| BET bromodomain inhibitor | |
| 5072 | PFI 3 |
| Potent and selective SMARCA2/4 and polybromo 1 inhibitor | |
| 5576 | PFI 4 |
| Potent and selective BRPF1B bromodomain inhibitor | |
| 7460 | SGC SMARCA-BRDVIII |
| Potent and selective SMARCA2/4 and PB1(bromo 5)-selective SWI/SNF bromodomain inhibitor | |
| 4889 | SGC-CBP30 |
| Potent CBP/p300 BRD inhibitor | |
| 6670 | TP 238 |
| CECR2 and BPTF/FALZ inhibitor | |
| 6000 | TP 472 |
| Potent BRD9/7 inhibitor | |
| 4132 | XMD 8-92 |
| BRD4 inhibitor; also ERK5/BMK1 inhibitor |
Cancer Research Product Guide
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyRequest PDFStem Cell Research Product Guide
Our guide highlights the use of small molecules in stem cell research and cell therapy and lists relevant products.
Request copyRequest PDFEpigenetics Scientific Review
Our Epigenetics review gives an overview of the development of chemical probes for epigenetic targets, and discusses their biological effects.
Request copyRequest PDFEpigenetics in Cancer Life Science Poster
Taken from the Cancer Product Guide Edition 3
Our Epigenetics in Cancer poster summarizes the main epigenetic targets in cancer, and highlights chemical compounds for the inhibition of these targets.
Request copyDownload PDFRheumatoid Arthritis Life Science Poster
Written by Adam P. Cribbs et al.
Our Rheumatoid Arthritis poster summarizes the disease pathology and highlights some of the epigenetic modifications associated with the condition.
Request copyDownload PDF